Tag: AlloCAR T

Clinical Trials, Research and Development

FDA Places Clinical Hold on Allogene CAR-T Cancer Trials

October 8, 2021

Via: Genetic Engineering and Biotechnology News

Allogene Therapeutics saw its shares fall more than 40% in early trading Friday after acknowledging that the FDA had placed a clinical hold on its trials evaluating its allogeneic CAR T (AlloCAR T) therapies for cancer. Allogene said the clinical […]